23 days ago
WST
AnalystsPaul KnightPaul Knight's Stock Forecasts
AnalystsPaul Knight
Analyst Ranking
Top 17%
#748 out of 4333 analysts
Average Return
+3.4%
Win Rate
45%45 out of 101
Risk vs Reward
Poor
Good
Paul Knight's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avid Bioservices IncCDMO | +303.75% | $8.26 | $33.35 | 2020-11-09 - 2021-11-09 | Strong Buy |
Cryoport IncCYRX | +186.11% | $5.47 | $15.65 | 2017-07-11 - 2018-07-12 | Strong Buy |
Oncocyte CorpOCX | +110.59% | $34.00 | $71.60 | 2020-11-09 - 2021-11-09 | Strong Buy |
Azenta IncAZTA | +107.18% | $59.43 | $123.13 | 2020-11-09 - 2021-11-09 | Strong Buy |
Harvard Bioscience IncHBIO | +95.38% | $3.90 | $7.62 | 2020-11-09 - 2021-11-09 | Strong Buy |
Paul Knight Analyst Color
Get additional color on Paul Knight's coverage of popular stocks
a month ago
WST
Paul Knight's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
West Pharmaceutical Services IncWST | 9 | Strong Buy | $440.00 | +17.55% | Maintains | 23 days ago |
Stevanato Group SpaSTVN | 5 | Strong Buy | $37.00 | +34.94% | Maintains | 23 days ago |
Castle Biosciences IncCSTL | 5 | Strong Buy | $25.00 | +50.06% | Maintains | 2 months ago |
Standard Biotools IncLAB | 1 | Strong Buy | $4.00 | +46.52% | Initiates Coverage On | 2 months ago |
Thermo Fisher Scientific IncTMO | 5 | Strong Buy | $640.00 | +27.59% | Maintains | 4 months ago |
Harvard Bioscience IncHBIO | 4 | Strong Buy | $7.00 | +69.90% | Maintains | 5 months ago |
Avid Bioservices IncCDMO | 3 | Strong Buy | $20.00 | +110.53% | Upgrades | 6 months ago |
Repligen CorpRGEN | 5 | Strong Buy | $240.00 | +48.40% | Maintains | 7 months ago |
Maravai Lifesciences Holdings IncMRVI | 7 | Strong Buy | $24.00 | +139.04% | Maintains | 7 months ago |
Bio Techne CorpTECH | 4 | Strong Buy | $115.00 | +64.47% | Maintains | 8 months ago |
Revvity IncRVTY | 4 | Strong Buy | $170.00 | +56.70% | Upgrades | 9 months ago |
Cryoport IncCYRX | 6 | Strong Buy | $30.00 | +120.59% | Maintains | 9 months ago |
Agilent Technologies IncA | 6 | Strong Buy | $165.00 | +50.37% | Maintains | 10 months ago |
Telesis Bio IncTBIO | 3 | Strong Buy | $5.00 | +306.50% | Maintains | 10 months ago |
Catalent IncCTLT | 4 | Strong Buy | $85.00 | +82.60% | Maintains | a year ago |
Azenta IncAZTA | 8 | Strong Buy | $70.00 | +43.86% | Maintains | a year ago |
Avantor IncAVTR | 5 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Danaher CorpDHR | 4 | Strong Buy | $325.00 | N/A | Maintains | a year ago |
Exagen IncXGN | 5 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Biolife Solutions IncBLFS | 3 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Charles River Laboratories International IncCRL | 1 | Strong Buy | $300.00 | N/A | Maintains | a year ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $250.00 | N/A | Maintains | a year ago |
Phenomex IncCELL | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Teleflex IncTFX | 1 | Strong Buy | $441.00 | N/A | Maintains | 3 years ago |
Icu Medical IncICUI | 1 | Strong Buy | $236.00 | N/A | Maintains | 3 years ago |
Cooper Companies IncCOO | 1 | Strong Buy | $396.00 | N/A | Maintains | 3 years ago |
Avanos Medical IncAVNS | 1 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Waters CorpWAT | 3 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Veracyte IncVCYT | 3 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Oncocyte CorpOCX | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |
Mesa Laboratories IncMLAB | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Illumina IncILMN | 1 | Hold | N/A | N/A | Upgrades | 6 years ago |
Nanostring Technologies IncNSTG | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Foundation Medicine IncFMI | 1 | Hold | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.